Investors

Capital Markets Day

Stockholm, February 5, 2019. PledPharma has the pleasure of inviting investors, financial analysts and media to PledPharmas’s Capital Markets Day (CMD) on 26th March 2019.  

PledPharma is an innovative, unique and integrated pharmaceutical drug development company, focusing on improving treatments for diseases with substantial unmet medical need. The company has the pleasure of inviting investors, financial analysts and media to PledPharmas’s Capital Markets Day (CMD) on 26th March 2019.

Time: Tuesday March 26th, at 10:00-15:00 CET

Venue: Redeye, Mäster Samuelsgatan 42, 10th floor, Stockholm

During the CMD, the company will provide an update and in-depth view on the company strategy and its assets covering the unmet medical need, commercial opportunities, development plans and additional activities to create and enhance value.

Speakers at the CMD include the Chairman of the Board, Håkan Åström, the CEO, Nicklas Westerholm and members from the management team as well as two key opinion leaders, Dr. James Dear, Edinburgh University and Prof. Per Pfeiffer, Odense University.

Presentations are held in English and a complete agenda will be presented in advance of the event.

The CMD will be broadcasted live at www.redeye.se/live/pled-kapitalmarknadsdag-2019

To attend – sign up here!

For further information, please contact:
Yilmaz Mahshid, CFO
Tel. +46-(0)72 231 68 00
yilmaz.mahshid@pledpharma.se

Share

Facebook
Twitter
LinkedIn
RSS

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com